Skip to main content
  • Careers
  • Investors
  • News
  • Partners
  • Health Professionals
  • Connect with Us
    • Email
    • FAQ
    • Privacy Policy
    • YouTube
    • Twitter
    • Facebook
    • LinkedIn
    • Instagram
  • EN
    • Argentina
    • Australia
    • Austria (link is external)
    • Belgium (link is external)
    • Brazil
    • Canada (link is external)
    • China
    • Colombia
    • Czech Republic (link is external)
    • Denmark (link is external)
    • Finland (link is external)
    • France (link is external)
    • Germany (link is external)
    • Greece (link is external)
    • Hong Kong
    • Hungary (link is external)
    • India (link is external)
    • Indonesia (link is external)
    • Ireland (link is external)
    • Israel (link is external)
    • Italy (link is external)
    • Japan (link is external)
    • Korea (link is external)
    • Malaysia/Singapore
    • Mexico
    • Netherlands (link is external)
    • New Zealand (link is external)
    • Norway (link is external)
    • Pakistan
    • Philippines
    • Poland
    • Portugal (link is external)
    • Romania (link is external)
    • Russia (link is external)
    • Slovakia (link is external)
    • South Africa (link is external)
    • Spain (link is external)
    • Sweden (link is external)
    • Switzerland (link is external)
    • Taiwan
    • Thailand (link is external)
    • Turkey
    • United Kingdom (link is external)
    • Ukraine (link is external)
Pfizer
  • YOUR HEALTH
    • Healthy Living
      • Brain & Nervous System
      • Cardiovascular Health
      • Cold & Flu
      • Digestive Health
      • Healthier Aging
      • Living Tobacco Free
      • Men’s Health
      • Mental Health
      • Nutrition & Fitness
      • Pediatric Health
      • Respiratory Health
      • Skin Health
      • Vaccines & Prevention
      • Women’s Health
    • Disease & conditions
      • Cancer
      • Cardiovascular Diseases & Conditions
      • Diabetes & Metabolic Disorders
      • Immune System Diseases & Conditions
      • Infections & Infectious Diseases
      • Neurological Diseases & Conditions
      • Menopause
      • Rare Disease
      • Vaccine-Related Conditions
      • Skin Diseases & Condition



    • CORONAVIRUS DISEASE (COVID-19)
    • Managing your health
      • Caregiving
      • Evaluating Health Information
      • Tracking Your Health
      • Your Medicines
      • Health Literacy
    • WELLNESS
    • Hot Topics
      • MAINTAINING EMOITONAL WELLBEING DURING COVID-19
  • OUR SCIENCE
    • DRIVEN TO DISCOVER THE CURE
    • FOCUS AREAS
      • Internal Medicine
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Anti Infectives
    • Product Pipeline
    • Clinical Trials
      • Guide to Clinical Trials
      • Find a Trial
      • Compassionate Use & Expanded Access
      • Clinical Trials in Children
      • Partnering with Pfizer
      • Trial Data & Results
      • Research Integrity & Transparency
    • R&D PLATFORMS
      • Biosimilars
      • Gene Therapy
      • Medicinal Sciences
      • Precision Medicine
      • Maternal Immunization
    • Collaboration
      • Partner with Pfizer
    • Research sites
    • CORONAVIRUS DISEASE (COVID-19) SCIENTIFIC RESOURCES
    • Hot Topics
      • COVID-19 Vaccine Candidates
      • MRNA VS. CONVENTIONAL
  • OUR PEOPLE
    • Meet The Experts
      • Scientists
      • Internal Medicine - Metabolic Disease
      • Inflammation &Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Medical Professionals
    • The Journey
    • Leadership
      • Executives
      • Board Members
      • Company Fact Sheet
    • Diverse Perspectives
      • Diversity & Inclusion
      • Supplier Diversity
    • Hot Topics
      • A day in the life of a Scientist
      • Getting to Know CPO Dara Richardson-Heron, M.D.
  • OUR PURPOSE
    • Commitment to Global Health
      • Expanding Access
      • Strengthening Health Systems
      • Providing Disaster & Humanitarian Relief
      • Unleashing the Power of Our Colleagues
      • Highlighting Individual Voices
    • Protecting People and the environment
      • Pfizer’s Green Journey
      • Product Stewardship
      • EHS Governance
      • EHS Supply Chain
      • Key Performance Indicators
      • Health & Safety
    • Positions on Health Policies
      • Ready for Cures
      • How does Pfizer price medicines?
      • Value of Medicines
      • Policy Positions
      • Creating Cures Through Facility Investments
    • Transparency
      • Working with Health Care Professionals
      • Transparency in Grants
      • Code of Conduct
      • Corporate Compliance
      • Sales and Marketing Compliance
    • INDEPENDENT GRANTS
      • Competitive Grants Program
      • Independent Medical Education
      • Investigator Sponsored Research
      • Quality Improvement
    • Contributions & Partnerships
      • Healthcare Charitable Contributions
      • Lobbying & Political Contributions
    • Hot Topics
      • Pfizer Women's Research Group
  • OUR PRODUCTS
    • Product listing
    • How drugs are made
      • Branded vs. Generic
      • Biologics & Biosimilars
      • Commitment to Quality
    • Upjohn
      • About Upjohn
      • Portfolio of Brands
      • Manufacturing Plants
      • UpJohn Leadership
    • Distributors
      • Pfizer Distributors
      • Greenstone Distributors
    • Medicine Safety
      • Reporting Adverse Events
      • Making Good Treatment Choices
      • Partnering With Patients
      • Health Literacy
      • Medicine Safety Tips for Patients
      • Counterfeiting
      • Unused Medicines
    • Safety Data Sheets
    • Medical Information Contacts
    • Pfizer Global Supply
    • Hot Topics
      • Scaling Up to Supply a COVID-19 Vaccine, If Approved
      • Universal vs. Single Payer Healthcare
  • Careers
    • About Us
      • Mission, Vission, Purpose
      • Our Businesses & Products
      • Key Facts About Our Sites
    • Search Jobs
    • Student Programs
    • Working at pfizer
    • Making a difference
    • Culture
    • Connect
    • Workplace Responsibility
    • R&D Careers
    • COMPANY FACT SHEET
  • Investors
  • News
    • Press Release Archive
    • Press Statements
    • Company Press Kit
    • Vaccines Press Kit
    • Get Old Press Kit
    • Pfizer Oncology Press Kit
    • RA NarRAtive
    • Frequently Requested Info
    • Contact Media Relations
  • Partners
    • Partnership Highlights
    • Contacts
    • Events Pfizer is Attending
    • Submit Your Opportunities
    • Biopharmaceuticals
    • Consumer Healthcare
    • Core Therapeutic Areas
    • Innovation
    • Research & Development
    • Venture Investments
      • Our portfolio
  • Health Professionals
  • Business to Business
  • Change Country
  • Sitemap
  • Contact Us
  • Terms of Use
  • Privacy Policy
Home/Viatris Transaction
Home/Viatris Transaction

Shareholder Resources


Information Statement

Distribution Tax Basis Information

Viatris FAQs to Pfizer Shareholders

Notification to Canadian Shareholders

  • Investors Overview
  • Why Invest - Our Story
    • Prospective Investors
    • Sustainability Bond
    • Fact Sheet
  • Events & Presentations
  • Financials
    • Quarterly Reports
    • Annual Reports
    • SEC Filings
    • Interactive Data Filings
    • Viatris Transaction
  • Investor News
  • Stock Information
    • Historical Stock Chart & Data
    • Investment Calculator
    • Historical Price Lookup
    • Dividend & Split History
    • Stock FAQs
  • Corporate Governance
    • Board Committees & Charters
    • The Pfizer Board Policies
    • Corporate Governance FAQs
    • Contact Our Directors
  • Shareholder Services
    • Stock FAQs
    • Cost Basis Calculator
    • Advisory Information
  • YOUR HEALTH
  • Healthy Living
  • Disease & Conditions
  • Managing Your Health
  • Our Science
  • Therapeutic Areas
  • Product Pipeline
  • Clinical Trials
  • R&D Platforms
  • Collaboration
  • Research Sites
  • OUR PEOPLE
  • Meet The Experts
  • The Journey
  • Leadership
  • Diverse Perspectives
  • OUR PURPOSE
  • Responsibility
  • Protecting the Environment
  • Positions on Health Policies
  • Transparency
  • Patient Assistance Program
  • Grants
  • Contributions & Partnerships
  • OUR PRODUCTS
  • Product Listing
  • How Drugs are Made
  • Distributors
  • Medicine Safety
  • Material Safety Data Sheets
  • Global Product Information Contacts
  • Career-seekers
  • Investors
  • News & Media
  • Partners
  • Health Professionals
  • Business to Business
  • Change Country
  • Sitemap
  • Contact Us
  • Terms of Use
  • Privacy Policy
Pfizer
Copyright © 2002-2021 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.

Forward-Looking Statements of Pfizer Inc.

This webcast may contain forward-looking statements about, among other things, our anticipated future operating and financial performance, business plans and prospects, in-line products and product candidates, strategic reviews, capital allocation, business-development plans, the benefits expected from the reorganization of our commercial operations into three businesses effective at the beginning of our 2019 fiscal year, our acquisitions and other business development activities, our proposed transaction with GSK to combine our respective consumer healthcare businesses into a new consumer healthcare joint venture, our ability to successfully capitalize on growth opportunities or prospects, manufacturing and product supply and plans relating to share repurchases and dividends, among other things, that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. 

A description of these risks and uncertainties can be found in Pfizer’s most recent Annual Report on Form 10-K and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

I Accept

Forward-Looking Statements of Pfizer Inc.

The following transcript contains forward-looking statements about our anticipated future financial performance that involve substantial risks and uncertainties. You can identify these statements by the fact that they use future dates or use words such as “will,” “may,” “could,” “likely,” “ongoing,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “assume,” “target,” “forecast,” “guidance,” “goal,” “objective,” “aim,” “seek” and other words and terms of similar meaning. Factors that could cause actual results to differ materially from past results and future plans and projected future results are described in our Form 8-K furnished with the U.S. Securities and Exchange Commission on January 12, 2021 and linked here, which also contains information regarding our use of preliminary financial guidance.

Continue